Cite
The Role of Stereotactic Frame-Based Biopsy for Brainstem Tumors in the Era of Molecular-Based Diagnosis and Treatment Decisions
MLA
Yudai Hirano, et al. “The Role of Stereotactic Frame-Based Biopsy for Brainstem Tumors in the Era of Molecular-Based Diagnosis and Treatment Decisions.” Current Oncology, vol. 29, no. 7, June 2022, pp. 4558–65. EBSCOhost, https://doi.org/10.3390/curroncol29070360.
APA
Yudai Hirano, Yuki Shinya, Toshiya Aono, Hirotaka Hasegawa, Mariko Kawashima, Masahiro Shin, Hirokazu Takami, Shunsaku Takayanagi, Motoyuki Umekawa, Masako Ikemura, Tetsuo Ushiku, Kazuki Taoka, Shota Tanaka, & Nobuhito Saito. (2022). The Role of Stereotactic Frame-Based Biopsy for Brainstem Tumors in the Era of Molecular-Based Diagnosis and Treatment Decisions. Current Oncology, 29(7), 4558–4565. https://doi.org/10.3390/curroncol29070360
Chicago
Yudai Hirano, Yuki Shinya, Toshiya Aono, Hirotaka Hasegawa, Mariko Kawashima, Masahiro Shin, Hirokazu Takami, et al. 2022. “The Role of Stereotactic Frame-Based Biopsy for Brainstem Tumors in the Era of Molecular-Based Diagnosis and Treatment Decisions.” Current Oncology 29 (7): 4558–65. doi:10.3390/curroncol29070360.